Literature DB >> 3516774

Vitreous fluorescein accumulation determined by in vivo fluorophotometry and by vitreous extraction in normal and diabetic rats.

F Kaufmann, C Lacoste.   

Abstract

Vitreous fluorophotometry was performed on pigmented male rats (Piebald strain) 2 weeks after induction of diabetes by streptozotocin. In vivo fluorophotometry data were compared with measurements obtained by direct extraction of the vitreous 60 min after an intravenous injection of sodium fluorescein. In addition, the rate of fluorescein disappearance from blood plasma, plasma protein binding of fluorescein and the effect of insulin treatment of diabetic animals were investigated. Age-matched nondiabetic animals served as controls. In vivo fluorophotometric measurements showed a good correlation with fluorescein determinations after direct extraction of the vitreous. Vitreous fluorescein concentrations were similar in diabetic and normal rats and were strongly related to the dye plasma levels within each group of animals. In the diabetic rats, however, the elimination of plasma fluorescein was accelerated and the percentage of free fluorescein, as determined by ultrafiltration and equilibrium dialysis, was consistently higher (130-150% of controls). The ratios of vitreous to total or free plasma fluorescein levels were elevated in diabetic rats. Experimental data indicate that plasma concentration of free fluorescein is crucial for vitreous dye accumulation. Insulin treatment of diabetic rats markedly improved their metabolic state and normalized the plasma fluorescein elimination and the vitreous to plasma fluorescein concentration ratios. It is concluded that vitreous fluorophotometry can be adequately applied to pigmented rats, provided that plasma fluorescein elimination rate and protein binding are considered in the interpretation of the results, since both influence the vitreous fluorescein accumulation and both may be altered by disease and drug treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3516774     DOI: 10.1007/bf02427089

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  Extraction of free fatty acids from plasma or serum in a continuous-flow system.

Authors:  E Lorch
Journal:  Anal Biochem       Date:  1969-04-04       Impact factor: 3.365

2.  Fluorophotometry. I. Technique.

Authors:  R Klein; J T Ernest; R L Engerman
Journal:  Arch Ophthalmol       Date:  1980-12

3.  Ocular fluorophotometry in streptozotocin diabetes mellitus in the rat: effect of pancreatic islet isografts.

Authors:  T Krupin; S R Waltman; D W Scharp; C Oestrich; S D Feldman; B Becker; W F Ballinger; P E Lacy
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-11       Impact factor: 4.799

4.  Vitreous fluorophotometry in adult-onset diabetes mellitus.

Authors:  S R Waltman; T Krupin; C Kilo; B Becker
Journal:  Am J Ophthalmol       Date:  1979-09       Impact factor: 5.258

5.  The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.

Authors:  T C Prager; H H Chu; C A Garcia; R E Anderson; J B Field; E A Orzeck; J P Comstock
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-01       Impact factor: 4.799

6.  Blood-ocular and blood-brain barrier function in streptozocin-induced diabetes in rats.

Authors:  O Mäepea; C Karlsson; A Alm
Journal:  Arch Ophthalmol       Date:  1984-09

7.  Renal function in streptozotocin-diabetic rats.

Authors:  P K Jensen; J S Christiansen; K Steven; H H Parving
Journal:  Diabetologia       Date:  1981-10       Impact factor: 10.122

8.  Clinicopathologic study of blood-retinal barrier in experimental diabetes mellitus.

Authors:  M O Tso; J G Cunha-Vaz; C Y Shih; C W Jones
Journal:  Arch Ophthalmol       Date:  1980-11

9.  Vitreous fluorophotometry: identification of sources of variability.

Authors:  T C Prager; D J Wilson; G D Avery; J H Merritt; C A Garcia; G Hopen; R E Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-12       Impact factor: 4.799

10.  Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control.

Authors:  N H White; S R Waltman; T Krupin; J V Santiago
Journal:  Diabetes       Date:  1982-01       Impact factor: 9.461

View more
  2 in total

1.  Changes in vitreal oxygen tension distribution in the streptozotocin diabetic rat.

Authors:  V A Alder; D Y Yu; S J Cringle; E N Su
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

2.  Titanium dioxide nanoparticles impair the inner blood-retinal barrier and retinal electrophysiology through rapid ADAM17 activation and claudin-5 degradation.

Authors:  Yen-Ju Chan; Po-Lin Liao; Chi-Hao Tsai; Yu-Wen Cheng; Fan-Li Lin; Jau-Der Ho; Ching-Yi Chen; Ching-Hao Li
Journal:  Part Fibre Toxicol       Date:  2021-01-09       Impact factor: 9.400

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.